Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Barrington Research boosted their Q1 2025 earnings per share estimates for Option Care Health in a report issued on Tuesday, January 14th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $0.22 per share for the quarter, up from their prior forecast of $0.20. Barrington Research currently has a "Outperform" rating and a $33.00 price target on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.21 per share. Barrington Research also issued estimates for Option Care Health's Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.20 EPS and FY2026 earnings at $1.42 EPS.
A number of other brokerages have also recently weighed in on OPCH. UBS Group started coverage on Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target for the company. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $26.00 to $33.00 in a report on Monday. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $29.86.
Get Our Latest Stock Report on Option Care Health
Option Care Health Price Performance
OPCH stock traded up $0.56 during midday trading on Thursday, hitting $29.32. 1,564,865 shares of the stock were exchanged, compared to its average volume of 2,244,667. The stock's 50-day moving average price is $23.44 and its 200-day moving average price is $27.71. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $4.99 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 2.44 and a beta of 1.31. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.
Insider Transactions at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company's stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.64% of the company's stock.
Institutional Investors Weigh In On Option Care Health
Several hedge funds have recently modified their holdings of the stock. UMB Bank n.a. raised its stake in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the period. Diversify Wealth Management LLC grew its stake in shares of Option Care Health by 31.7% during the 4th quarter. Diversify Wealth Management LLC now owns 13,560 shares of the company's stock valued at $325,000 after buying an additional 3,261 shares during the period. Wedge Capital Management L L P NC acquired a new stake in shares of Option Care Health during the 4th quarter worth $3,245,000. Assenagon Asset Management S.A. raised its position in shares of Option Care Health by 128.2% in the 4th quarter. Assenagon Asset Management S.A. now owns 292,090 shares of the company's stock worth $6,776,000 after buying an additional 164,086 shares during the period. Finally, Graypoint LLC purchased a new position in shares of Option Care Health in the 4th quarter worth $1,161,000. 98.05% of the stock is owned by institutional investors and hedge funds.
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
